GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Guangxi LiuYao Group Co Ltd (SHSE:603368) » Definitions » ROE %

Guangxi LiuYao Group Co (SHSE:603368) ROE % : 17.75% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Guangxi LiuYao Group Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Guangxi LiuYao Group Co's annualized net income for the quarter that ended in Mar. 2024 was ¥1,201 Mil. Guangxi LiuYao Group Co's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was ¥6,768 Mil. Therefore, Guangxi LiuYao Group Co's annualized ROE % for the quarter that ended in Mar. 2024 was 17.75%.

The historical rank and industry rank for Guangxi LiuYao Group Co's ROE % or its related term are showing as below:

SHSE:603368' s ROE % Range Over the Past 10 Years
Min: 10.68   Med: 14.31   Max: 20.5
Current: 13.72

During the past 13 years, Guangxi LiuYao Group Co's highest ROE % was 20.50%. The lowest was 10.68%. And the median was 14.31%.

SHSE:603368's ROE % is ranked better than
74.47% of 94 companies
in the Medical Distribution industry
Industry Median: 6.915 vs SHSE:603368: 13.72

Guangxi LiuYao Group Co ROE % Historical Data

The historical data trend for Guangxi LiuYao Group Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangxi LiuYao Group Co ROE % Chart

Guangxi LiuYao Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.68 15.03 10.68 12.28 13.50

Guangxi LiuYao Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 11.71 14.65 10.72 17.75

Competitive Comparison of Guangxi LiuYao Group Co's ROE %

For the Medical Distribution subindustry, Guangxi LiuYao Group Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangxi LiuYao Group Co's ROE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangxi LiuYao Group Co's ROE % distribution charts can be found below:

* The bar in red indicates where Guangxi LiuYao Group Co's ROE % falls into.



Guangxi LiuYao Group Co ROE % Calculation

Guangxi LiuYao Group Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=849.592/( (5968.965+6617.615)/ 2 )
=849.592/6293.29
=13.50 %

Guangxi LiuYao Group Co's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=1201.396/( (6617.615+6917.964)/ 2 )
=1201.396/6767.7895
=17.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


Guangxi LiuYao Group Co  (SHSE:603368) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=1201.396/6767.7895
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(1201.396 / 23098.672)*(23098.672 / 20402.604)*(20402.604 / 6767.7895)
=Net Margin %*Asset Turnover*Equity Multiplier
=5.2 %*1.1321*3.0147
=ROA %*Equity Multiplier
=5.89 %*3.0147
=17.75 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=1201.396/6767.7895
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (1201.396 / 1446.264) * (1446.264 / 1819.82) * (1819.82 / 23098.672) * (23098.672 / 20402.604) * (20402.604 / 6767.7895)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8307 * 0.7947 * 7.88 % * 1.1321 * 3.0147
=17.75 %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Guangxi LiuYao Group Co ROE % Related Terms

Thank you for viewing the detailed overview of Guangxi LiuYao Group Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangxi LiuYao Group Co (SHSE:603368) Business Description

Traded in Other Exchanges
N/A
Address
No. 68 Guantang Avenue, Guangxi Zhuang Autonomous Region, Liuzhou, CHN, 545000
Guangxi LiuYao Group Co Ltd is a regional pharmaceutical distribution enterprise focusing on hospital sales and developing both retail pharmacies and third terminals.
Executives
Tang Xian Rong Director
Chen Hong Directors, senior managers
Tang Chun Xue Directors, senior managers
Zhang Hua Director
Ceng Xiang Xing senior management
Zhu Xian Hua senior management
Su Chun Yan senior management
Chen Xiao Yuan Supervisors
Zhu Chao Yang Directors, senior managers
Tang Jie Yu senior management
Qiu Zhi Meng senior management
Shen Wen Jie senior management
Xiao Jun Xiong Director
Ceng Song Lin Director

Guangxi LiuYao Group Co (SHSE:603368) Headlines

No Headlines